PI-1840
Selleck Chemicals
SKU:S7462-10MG
Couldn't load pickup availability

PI-1840 is an inhibitor of Proteasome used in studies of Protein Degradation / Proteasome. It is especially relevant in cancer and protein homeostasis models, where defined compound exposure can be linked to ubiquitin-dependent turnover, proteostasis, and targeted protein degradation.
By inhibiting Proteasome, PI-1840 can be used to examine ubiquitin-dependent turnover, proteostasis, and targeted protein degradation. The protease annotation adds relevance to protease-activity, cleavage, and substrate-processing assays, together with downstream-response mapping in the same experimental setting. In cancer and protein homeostasis models, these readouts can be combined with viability, reporter, localization, biochemical conversion, or morphology endpoints to refine experimental interpretation.
Research Applications
- Target-focused assays involving Proteasome
- Pathway perturbation studies connected to Protein Degradation / Proteasome
- Concentration-response inhibition and target-dependence studies
- Protease-activity, cleavage, and substrate-processing assays
Overall, PI-1840 is appropriate when a defined chemical perturbant is needed to connect Proteasome with measurable biochemical, transcriptional, electrophysiological, imaging, or phenotypic readouts in cancer and protein homeostasis models. This profile is suited to mechanistic follow-up, comparative profiling, and assay optimization under defined exposure conditions.
- Targets:
- Proteasome
- Target Class:
- Protease
- Pathways:
- Protein Degradation / Proteasome
- Research Area:
- Cancer • Protein Homeostasis
- CAS No.:
- 1401223-22-0
- Molecular Weight:
- 394.47
- Formula:
- C₂₂H₂₆N₄O₃
- SMILES:
- CCCC1=CC=C(C=C1)OCC(=O)N(CC2=NC(=NO2)C3=CN=CC=C3)C(C)C
- Storage Temperature:
- -20°C
For Research Use Only. Not intended for diagnostic or therapeutic use.
Products may be subject to intellectual property rights.
The purchase of this product does not grant any license for commercial use, manufacturing, or clinical applications. The user is responsible for ensuring compliance with applicable laws and third-party rights.